Skip to main content
. 2021 Mar 16;144(6):1869–1883. doi: 10.1093/brain/awab094

Figure 3.

Figure 3

Amyloid-β42 level is not influenced by terminal systemic infection. Scatterplots showing amyloid-β42 (Aβ42) level in guanidine-HCl extracts (insoluble Aβ42) in superior temporal cortex (BA22) in Alzheimer’s disease (AD), vascular dementia (VaD) and age-matched controls, stratified for the absence or presence of terminal systemic infection. Each point represents the mean of duplicate measurements for an individual. Horizontal bars indicate the cohort mean ± SEM. *Significant compared to age-matched control. ***P < 0.001.